New!
Volume 3, Issue 1 (2011) of Neurological Bulletin is now available online.
Publications from 1992
Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats, Kazuo Minematsu, Limin Li, Christopher H. Sotak, Michael A. Davis, and Marc Fisher
Inhibition of lipid deposition in the hypercholesterolemic rat by clentiazem, a calcium channel blocker, John J. Nunnari, Marc Fisher, and Stanley D. T. White
Incontinence and troublesome behaviors predict institutionalization in dementia, Brian F. O'Donnell, David A. Drachman, Heather J. Barnes, Karen E. Peterson, Joan M. Swearer, and Robert A. Lew
Active and passive P3 latency and psychometric performance: influence of age and individual differences, Brian F. O'Donnell, Susan Friedman, Joan M. Swearer, and David A. Drachman
Analysis of the prion protein gene in thalamic dementia, R. B. Petersen, M. Tabaton, L. Berg, B. Schrank, R. M. Torack, S. Leal, J. Julien, C. Vital, B. Deleplanque, W. W. Pendlebury, and David A. Drachman
Antithrombotic therapy for cerebrovascular disorders, David G. Sherman, Mark L. Dyken, Marc Fisher, Michael Gent, Michael J. G. Harrison, and Robert G. Hart
Neuropsychological features of familial Alzheimer's disease, Joan M. Swearer, Brian F. O'Donnell, David A. Drachman, and Beatrice M. Woodward
Publications from 1991
Meeting report: Antidementia drug assessment symposium, David A. Drachman
Section of geriatric neurology, David A. Drachman
Progressive External Ophthalmoplegia, David A. Drachman and David A. Chad
Atherosclerosis: cellular aspects and potential interventions, Marc Fisher
Ischemic cerebral vascular disease: an overview, Marc Fisher
A 21-aminosteroid inhibits stimulated monocyte hydrogen peroxide and chemiluminescence measurements from MS patients and controls, Marc Fisher, Peter H. Levine, Elizabeth M. Doyle, Margaret M. Arpano, D. A. Bergeron, Ronald A. Cohen, and James J. Hoogasian
A 21-aminosteroid inhibits oxidation of human low density lipoprotein by human monocytes and copper, Marc Fisher, Peter H. Levine, Elizabeth M. Doyle, Margaret M. Arpano, and James J. Hoogasian
Expression of heat shock proteins in Alzheimer's disease, James E. Hamos, B. Oblas, D. Pulaski-Salo, W. J. Welch, D. G. Bole, and David A. Drachman
Thrombosis in a congenitally bifurcated superior sagittal sinus, Mark A. Hosley, Marc Fisher, and James F. Lingley
Primary progressive aphasia with focal neuronal achromasia, Carol F. Lippa, R. Cohen, Thomas W. Smith, and David A. Drachman
Publications from 1990
Dizziness and Vertigo: Common and Less Common Causes, David A. Drachman
The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course, David A. Drachman, Brian F. O'Donnell, Robert A. Lew, and Joan M. Swearer
Alzheimer's disease, David A. Drachman and Joan M. Swearer
A 21-aminosteroid reduces hydrogen peroxide generation by and chemiluminescence of stimulated human leukocytes, Marc Fisher, Peter H. Levine, and Ronald A. Cohen
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis, Carlos S. Kase, Angela M. O'Neal, Marc Fisher, Gigi N. Girgis, and Joe I. Ordia
First report of the congressionally appointed Advisory Panel on Alzheimer's Disease, Eric B. Larson, Robert Katzman, Elaine M. Brody, and David A. Drachman
The indusium griseum: is it involved in Alzheimer's disease, Carol F. Lippa, Thomas W. Smith, Umberto DeGirolami, and David A. Drachman
Active and Passive P3 Latency in Dementia: Relationship to Psychometric, Electroencephalographic, and Computed Tomographic Measures, Brian F. O'Donnell, Susan Friedman, Nancy K. Squires, Alan Maloon, David A. Drachman, and Joan M. Swearer
Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model, David A. Phillips, Marc Fisher, Michael A. Davis, Thomas W. Smith, and Roy H.L. Pang
Publications from 1989
Amantadine treatment of fatigue associated with multiple sclerosis, Ronald A. Cohen and Marc Fisher
Thalamic dementia and motor neuron disease, Feza Deymeer, Thomas W. Smith, Umberto DeGirolami, and David A. Drachman
Clinical and research applications: An overview, David A. Drachman
Novel drug delivery systems: opportunities and caveats, David A. Drachman
n-3 fatty acids and cellular aspects of atherosclerosis, Marc Fisher, Peter H. Levine, and Alexander Leaf
Brain tumor presenting as an acute pure motor hemiparesis, Marc Fisher and Lawrence D. Recht
Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis, Scott H. Goodnight, Marc Fisher, Garret A. FitzGerald, and Peter H. Levine
Synaptic loss in Alzheimer's disease and other dementias, James E. Hamos, Louis J. DeGennaro, and David A. Drachman
The effects of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolic stroke model, David A. Phillips, Marc Fisher, Thomas W. Smith, Michael A. Davis, and Roy H.L. Pang
Tumor-associated aphasia in left hemisphere primary brain tumors: the importance of age and tumor grade, Lawrence D. Recht, K. McCarthy, Brian F. O'Donnell, R. Cohen, and David A. Drachman
Antithrombotic therapy for cerebrovascular disorders, David G. Sherman, Mark L. Dyken, Marc Fisher, Michael J. G. Harrison, and Robert G. Hart
Atherosclerosis: current concepts on pathogenesis and interventional therapies, Frank M. Yatsu and Marc Fisher
Cardiogenic brain embolism and lupus anticoagulant, Seymour M. Young, Marc Fisher, Ann Sigsbee, and Annmarie Errichetti
Publications from 1988
Who may drive? Who may not? Who shall decide, David A. Drachman
Ischemic stroke after cardiac pacemaker implantation in sick sinus syndrome, Marc Fisher, Carlos S. Kase, Barbara Stelle, and Roger M. Mills Jr.
Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis, Marc Fisher, Peter H. Levine, Bonnie H. Weiner, Christine H. Vaudreuil, Anita M. Natale, Mark H. Johnson, and James J. Hoogasian
Pure motor hemiplegia secondary to a saccular basilar artery aneurysm, Marc Fisher, Thomas W. Smith, and Richard Jacobs
Measuring dementia: assessment of multiple deficit domains, Brian F. O'Donnell, David A. Drachman, Robert A. Lew, and Joan M. Swearer
Selective embolization and clot dissolution with tPA in the internal carotid artery circulation of the rabbit, David A. Phillips, Michael A. Davis, and Marc Fisher
The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model, David A. Phillips, Marc Fisher, Thomas W. Smith, and Michael A. Davis
Molecular genetics of dominant familial Alzheimer's disease, Peter H. St.George-Hyslop and David A. Drachman
Molecular genetic strategies in familial Alzheimer's disease: Theoretical and practical considerations, Peter H. St.George-Hyslop and David A. Drachman
Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity, Joan M. Swearer, David A. Drachman, Brian F. O'Donnell, and Ann L. Mitchell
Publications from 1987
Bell's palsy, David A. Chad and David A. Drachman
Bell's palsy, David A. Drachman and David A. Chad
The importance of carotid artery plaque disruption and hemorrhage, Marc Fisher, Andrew M. Blumenfeld, and Thomas W. Smith
Linoleic acid levels in white blood cells, platelets, and serum of multiple sclerosis patients, Marc Fisher, Mark H. Johnson, Anita M. Natale, and Peter H. Levine
Genetic linkage analysis of familial Alzheimer's disease, J. F. Gusella and David A. Drachman
Motor neuron disease and paraproteinemia, Stacy A. Rudnicki, David A. Chad, David A. Drachman, Thomas W. Smith, Ursula E. Anwer, and N. Levitan
Vacuolar change in Alzheimer's disease, Thomas W. Smith, Ursula E. Anwer, Umberto DeGirolami, and David A. Drachman
Search for the familial Alzheimer's disease gene, Peter H. St.George-Hyslop, Ronald J. Polinsky, Jonathan L. Haines, Linda Nee, Rudolph E. Tanzi, P. Michael Conneally, John Growdon, Richard H. Myers, Daniel A. Pollen, and David A. Drachman
The genetic defect causing familial Alzheimer's disease maps on chromosome 21, Peter H. St.George-Hyslop, Rudolph E. Tanzi, Ronald J. Polinsky, Jonathan L. Haines, Linda Nee, Paul C. Watkins, Richard H. Myers, Robert G. Feldman, Daniel A. Pollen, and David A. Drachman
Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease, Peter H. St.George-Hyslop, Rudolph E. Tanzi, Ronald J. Polinsky, Rachael L. Neve, Daniel A. Pollen, David A. Drachman, John Growdon, L. Adrienne Cupples, Linda Nee, and Richard H. Myers
Brachial neuropathy after brachial artery-antecubital vein shunts for chronic hemodialysis, Lydia Wytrzes, Herbert G. Markley, Marc Fisher, and Howard J. Alfred
Publications from 1986
Plaques and tangles in Alzheimer's Disease: Cause, consequence or epiphenomenon?, David A. Drachman
The potential clinical benefits of fish consumption, Marc Fisher, Peter H. Levine, and Bonnie H. Weiner
Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential, Marc Fisher, Katherine S. Upchurch, Peter H. Levine, Mark H. Johnson, Christine H. Vaudreuil, Anita M. Natale, and James J. Hoogasian
Cholinergic enhancement and REM sleep latency in the aged: lecithin does not reproduce physostigmine effect, Sheldon Kapen, Peter D. Fleming, and David A. Drachman
Unruptured intracranial aneurysm and transient focal cerebral ischemia: a follow-up study, Monica M. Przelomski, Marc Fisher, Robin I. Davidson, H. Royden Jones, and Elliott M. Marcus
Cerebral embolism, David G. Sherman, Mark L. Dyken, Marc Fisher, Michael J. G. Harrison, and Robert G. Hart
Publications from 1985
Treatment of Alzheimer's disease: New outlooks for the future, David A. Drachman
Hypertensive encephalopathy: diffuse reversible white matter CT abnormalities, Marc Fisher, Bernard Maister, and Richard Jacobs
Status epilepticus and Epstein-Barr virus encephalopathy. Diagnosis by modern serologic techniques, James Russell, Marc Fisher, Justin A. Zivin, John L. Sullivan, and David A. Drachman
Tissue plasminogen activator reduces neurological damage after cerebral embolism, Justin A. Zivin, Marc Fisher, Umberto DeGirolami, Carl C. Hemenway, and Joan A. Stashak
Publications from 1984
Treatment of Alzheimer's disease: New outlooks for the future, David A. Drachman
Neurological evaluation of the elderly patient, David A. Drachman and Randall R. Long
Selective thromboxane inhibition: a new approach to antiplatelet therapy, Marc Fisher, Bonnie H. Weiner, Ira S. Ockene, James S. Hoogasian, Anita M. Natale, John R. Arsenault, Mark H. Johnson, and Peter H. Levine
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Guy M. McKhann, David A. Drachman, Marshall F. Folstein, Robert Katzman, Donald L. Price, and Emanuel M. Stadlan
Publications from 1983
Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease, J. P. Blass, M. J. Reding, and David A. Drachman
Aging and dementia: insights from the study of anticholinergic drugs, David A. Drachman
How normal aging relates to dementia: A critique and classification, David A. Drachman
The pharmacological basis for cholinergic investigation of Alzheimer's disease: Evidence and implications, David A. Drachman
Computer aids in neurological diagnosis, David A. Drachman and Robert A. Lew
Focal cerebral ischemia and mitral valve prolapse in monozygotic twins, Marc Fisher and Edward Budnitz
Hand muscle atrophy in multiple sclerosis, Marc Fisher, Randall R. Long, and David A. Drachman
Focal cerebral ischemia distal to a cerebral aneurysm in hereditary hemorrhagic telangiectasia, Marc Fisher and Joseph L. Zito
Publications from 1982
The multidimensional assessment for dementia scales, David A. Drachman, Peter D. Fleming, and Guila Glosser
Memory decline in the aged: treatment with lecithin and physostigmine, David A. Drachman, Guila Glosser, Peter D. Fleming, and R. Gerald Longenecker
Marker proteins of platelet activation in patients with cerebrovascular disease, Marc Fisher, Peter H. Levine, Albert L. Fullerton, Ann D. Forsberg, Celeste P. Duffy, James J. Hoogasian, and David A. Drachman
Propranolol, hallucinations, and sleep disturbance, Peter D. Fleming and David A. Drachman
Publications from 1981
The cholinergic system, memory and aging, David A. Drachman
Pharmacologic strategies in aging and dementia: The cholinergic hypothesis, David A. Drachman and Guila Glosser
Bilateral cortical border-zone infarction. A pseudobrainstem stroke, Marc Fisher and James B. McQuillen
Human platelet factor 4: preparation from outdated platelet concentrates and application in cerebral vascular disease, Peter H. Levine, Marc Fisher, Albert L. Fullerton, Celeste P. Duffy, and James J. Hoogasian
Intramedullary spinal cord metastasis, Peter R. Sebastian, Marc Fisher, Thomas W. Smith, and Robin I. Davidson
Publications from 1980
An approach to the neurology of aging, David A. Drachman
Aging, memory, and the cholinergic system: a study of dichotic listening, David A. Drachman, Douglas Noffsinger, B. J. Sahakian, Sabina A. Kurdziel, and Peter D. Fleming
Memory, aging and pharmacosystems, David A. Drachman and B. J. Sahakian
Memory and cognitive function in the elderly. A preliminary trial of physostigmine, David A. Drachman and B. J. Sahakian
Transient focal cerebral ischemia as a presenting manifestation of unruptured cerebral aneurysms, Marc Fisher, Robin I. Davidson, and Elliott M. Marcus
Publications from 1979
Central cholinergic system and memory, David A. Drachman
Dizziness and vertigo, David A. Drachman
Dizziness and disorders of equilibrium--panel 8, David A. Drachman, Ronald I. Apfelbaum, and Jerome B. Posner
Effects of Cholinergic Agents on Human Learning and Memory, David A. Drachman and B. J. Sahakian